| Ytd | -2.75% | |
| 1y | -16.92% |
| Open | 92.33 | Prev Close | 92.33 | Low | 91.93 | High | 93.15 | Mkt Cap | 23.35B |
| Vol | 139.16K | Avg Vol | 925.18K | EPS | -4.62 | P/E | -19.98 | Forward P/E | 7.04 |
| Beta | 1.32 | Short Ratio | 2.24 | Inst. Own | 20.48% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | 06-02 | Earning | 08-04 | 50-d Avg | 91.31 | 200-d Avg | 98.73 | 1yr Est | 122.51 |
MAINZ, Germany, July 21 , 2026 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Comp
Baader Bank Aktiengesellschaft lowered its stake in BioNTech SE Sponsored ADR (NASDAQ: BNTX) by 10.4
Amova Asset Management Americas Inc. acquired a new position in shares of BioNTech SE Sponsored ADR
Arbutus and its exclusive licensee, Genevant, filed three international lawsuits seeking to enforce
On July 8, the Ark Genomic Revolution ETF sold roughly $7.4 million worth of BioNTech stock. Cathie
Morgan Stanley analyst Terence Flynn maintains BioNTech (NASDAQ:BNTX) with a Overweight and lower
They may not remain cheap for too much longer.
BioNTech has held confidential talks with potential buyers about the German sites that the COVID‑1
U.S. pharmaceutical company Moderna is interested in investing in production facilities in German
Arcus Biosciences teams up with Bristol Myers Squibb to test casdatifan combinations in kidney cance
BMY unveils strong ASCO data for mezigdomide and pumitamig, highlighting late-stage pipeline progres
First investigational PD-(L)1xVEGF bispecific immunomodulator to present global data showing encoura
Pumitamig data from the ongoing Phase 2/3 ROSETTA Lung-02 trial in first-line non-small cell lung ca
MAINZ, Germany, May 15, 2026 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Compa
BioNTech NASDAQ: BNTX used its virtual annual general meeting to outline a transition year marked by
The hantavirus isn't as contagious as the coronavirus, making a global pandemic unlikely. Picking th
MAINZ, Germany, May 7, 2026 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Compan
BioNTech SE is downgraded to Sell due to declining COVID vaccine revenues, leadership exits, and pip
A German government spokesperson said on Wednesday that the loss of BioNTech vaccine production
BioNTech SE (BNTX) Q1 2026 Earnings Call Transcript
Shares of BioNTech SE (NASDAQ:BNTX) are trading lower on Tuesday as the company reported mixed first
The company said it would exit operations at some manufacturing plants in Germany and Singapore, as
US stock futures mixed, SanDisk (NASDAQ: SNDK) shares drop 5.6% in pre-market following strong Q3 re
Dow falls 200+ points as Serve Robotics Inc (NASDAQ: SERV) shares rise 16.2% on better-than-expected
US stocks rise with Dow up over 300 points, S&P 500 and NASDAQ also gaining. Kohl's Corp sha
US stocks mixed, Dow down 0.1%, NASDAQ up 0.13%, S&P 500 down 0.08%. Materials sector up, utilit
US stock futures lower, FreightCar America (RAIL) plunges after weak earnings. Other stocks moving l
Investors are anticipating earnings releases from Oracle, Ulta, Adobe, Dick's, AeroVironment and
Ten large-cap stocks led last week's gains, driven by upbeat earnings, guidance, buybacks, and k
The FDA may approve updated COVID-19 vaccines this week to combat recent strains as the country endu
U.S. stock futures traded higher this morning, with the Dow Jones futures gaining more than 80 point
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earn
Thursday's session saw 189 companies set new 52-week lows.
On Wednesday, 329 companies hit new 52-week lows.
During Wednesday's morning trading, 125 companies set new 52-week highs.
Before 10 a.m. ET Monday, 296 stocks made new 52-week highs.
Before 10 a.m. ET on Tuesday, 166 companies hit new 52-week highs.
Monday's morning session saw 253 companies set new 52-week highs.
During Wednesday's morning session, 226 stocks hit new 52-week highs.
Stocks That Hit 52-Week Highs On Tuesday